Pfizer, Gilead, GSK to lead $150 bn infectious diseases mkt by 2029: Report

Pharma giants Pfizer, Gilead Sciences, and GSK are expected to collectively generate 62 per cent of total infectious disease drug sales between 2023 and 2029, according to a report on Wednesday.